These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials. Grais RF; Kennedy SB; Mahon BE; Dubey SA; Grant-Klein RJ; Liu K; Hartzel J; Coller BA; Welebob C; Hanson ME; Simon JK Lancet Microbe; 2021 Feb; 2(2):e70-e78. PubMed ID: 35544244 [TBL] [Abstract][Full Text] [Related]
14. Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America. Martinez-Murillo PA; Huttner A; Lemeille S; Medaglini D; Ottenhoff THM; Harandi AM; Didierlaurent AM; Siegrist CA Front Immunol; 2023; 14():1279003. PubMed ID: 38235127 [TBL] [Abstract][Full Text] [Related]